These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 940021)

  • 1. Effective long-term treatment of pseudohypoparathyroidism with oral 1alpha-hydroxy- and 1,25-dihydroxy-cholecalciferol.
    Werder EA; Kind HP; Egert F; Fischer JA; Prader A
    J Pediatr; 1976 Aug; 89(2):266-8. PubMed ID: 940021
    [No Abstract]   [Full Text] [Related]  

  • 2. Probable autosomal recessive inheritance in a family with Albright's hereditary osteodystrophy and an evaluation of the genetics of the disorder.
    Cederbaum SD; Lippe BM
    Am J Hum Genet; 1973 Nov; 25(6):638-45. PubMed ID: 4359274
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW; Brickman AS
    Adv Exp Med Biol; 1978; 103():473-86. PubMed ID: 362852
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
    Chesney RW; Hamstra A; Jax DK; Mazess RB; DeLuca HF
    Contrib Nephrol; 1980; 18():55-71. PubMed ID: 7353380
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of pseudohypoparathyroidism: an informative family study.
    Barr DG; Stirling HF; Darling JA
    Arch Dis Child; 1994 Apr; 70(4):337-8. PubMed ID: 8185370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
    J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of pseudovitamin D deficiency-like rickets in an infant treated with 1,25-dihydroxycholecalciferol. Preliminary note.
    Vecchio F; Carnevale F; Paganetti G; di Bitonto G; Marinelli G
    J Inherit Metab Dis; 1978; 1(4):183-5. PubMed ID: 117256
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H; Bordier P
    Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to vitamin D and parathyroid hormone.
    Moses AM
    N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrence of features of pseudohypoparathyroidism, pseudopseudohypoparathyroidism and basal-cell nevus syndrome.
    Chopra IJ; Nugent CA
    Am J Med Sci; 1970 Sep; 260(3):171-83. PubMed ID: 5480625
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs.
    Keck E; Gollnick B; Reinhardt D; Karch D; Peerenboom H; Krüskemper HL
    Eur J Pediatr; 1982 Sep; 139(1):52-5. PubMed ID: 7173258
    [No Abstract]   [Full Text] [Related]  

  • 18. [GNAS1 gene abnormality in pseudohypoparathyroidism I a].
    Ozono K
    Clin Calcium; 2007 Aug; 17(8):1214-9. PubMed ID: 17660618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
    Wright DR
    N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.